We are live on ! Find out more
SIG

Sargent Investment Group Portfolio holdings

AUM $759M
1-Year Est. Return 28.58%
This Fund
S&P 500
This Quarter Est. Return
+11.82%
1 Year Est. Return
+28.58%
3 Year Est. Return
+104.74%
5 Year Est. Return
+107.13%
10 Year Est. Return
AUM
$379M
AUM Growth
+$57.2M
Cap. Flow
+$27.3M
Cap. Flow %
7.19%
Top 10 Hldgs %
36%
Holding
217
New
24
Increased
89
Reduced
62
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 25.02%
2 Healthcare 12.53%
3 Financials 10.92%
4 Industrials 7.23%
5 Consumer Discretionary 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISV
176
Fiserv Inc
FISV
$27.9B
$217K 0.06%
+1,920
New +$211K
LVS icon
177
Las Vegas Sands
LVS
$29.6B
$212K 0.06%
+3,615
New +$202K
PANW icon
178
Palo Alto Networks
PANW
$297B
$209K 0.06%
+2,130
New +$181K
NVO
179
Novo Nordisk
NVO
$209B
$207K 0.05%
2,600
-400
-13% -$28.4K
URI icon
180
United Rentals
URI
$72.4B
$207K 0.05%
+533
New +$224K
PYPL icon
181
PayPal
PYPL
$50.5B
$205K 0.05%
+2,725
New +$210K
DIS icon
182
Walt Disney
DIS
$181B
$205K 0.05%
+2,050
New +$207K
VTHR icon
183
Vanguard Russell 3000 ETF
VTHR
$4.85B
$203K 0.05%
+1,105
New +$198K
ITM icon
184
VanEck Intermediate Muni ETF
ITM
$2.15B
$202K 0.05%
+4,343
New +$200K
FOF icon
185
Cohen & Steers Closed End Opportunity Fund
FOF
$380M
$166K 0.04%
15,085
-4,000
-21% -$44.9K
ARDX icon
186
Ardelyx
ARDX
$997M
$160K 0.04%
33,951
+11,468
+51% +$38.7K
CBIO
187
Crescent Biopharma
CBIO
$626M
$135K 0.04%
+1,080
New +$243K
TARS icon
188
Tarsus Pharmaceuticals
TARS
$2.84B
$133K 0.04%
10,579
+221
+2% +$3.23K
WULF icon
189
TeraWulf
WULF
$8.52B
$103K 0.03%
+100,000
New +$74.6K
SIRI icon
190
SiriusXM
SIRI
$10.1B
$75.6K 0.02%
1,910
EXEL icon
191
CALL
Exelixis
EXEL
$13.4B
$56K 0.01%
+35,000
New +$610K
LONA
192
LeonaBio Inc
LONA
$72.1M
$51.1K 0.01%
2,027
+515
+34% +$16.6K
INTZ
193
DELISTED
INTRUSION INC NEW
INTZ
$35.5K 0.01%
30,455
+400
+1% +$466
RLMD icon
194
Relmada Therapeutics
RLMD
$527M
$33.9K 0.01%
+14,317
New +$49.4K
TELL
195
DELISTED
Tellurian Inc.
TELL
$25K 0.01%
20,000
-30,000
-60% -$47.8K
TSHA icon
196
Taysha Gene Therapies
TSHA
$1.89B
$15.1K ﹤0.01%
19,569
-23,418
-54% -$30.3K
UAMY icon
197
United States Antimony
UAMY
$1.02B
$7.33K ﹤0.01%
20,000
-300,000
-94% -$123K
CHRS icon
198
Coherus Oncology
CHRS
$196M
-11,200
Closed -$88.7K
DE icon
199
Deere & Co
DE
$168B
-650
Closed -$279K
DUK icon
200
Duke Energy
DUK
$97.3B
-2,069
Closed -$213K

Similar funds

Sargent Investment Group's Q1 2023 Portfolio in Review

As of Q1 2023, Sargent Investment Group held 217 positions worth $379M, up 18% from $322M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sargent Investment Group deployed $27.3M of net new capital in Q1 2023, opening 24 new positions and adding to 89 existing holdings. Its largest new stake was State Street SPDR Bloomberg 3-12 Month T-Bill ETF: 163,079 shares worth $16.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Block Inc, an estimated $2.87M trimmed.

  • Sargent Investment Group's largest Q1 2023 buy was State Street SPDR Bloomberg 3-12 Month T-Bill ETF: 163,079 shares worth $16.2M.
  • Sargent Investment Group added most to Energy Recovery in Q1 2023, an estimated $3.28M increase.
  • Sargent Investment Group's biggest Q1 2023 reduction was Block Inc, cutting an estimated $2.87M.
  • Sargent Investment Group fully exited First Trust Dow Jones Internet Index Fund ETF in Q1 2023, selling an estimated $1.26M.
  • Sargent Investment Group's ten largest holdings make up 36% of its $379M portfolio in Q1 2023.
  • Sargent Investment Group opened 24 new positions and closed 18 in Q1 2023.
  • Sargent Investment Group's portfolio value rose 18% quarter-over-quarter to $379M.

Based on Sargent Investment Group's 13F filing for Q1 2023, filed 2 May 2023.